메뉴 건너뛰기




Volumn 2013, Issue , 2013, Pages

Biological treatments: New weapons in the management of monogenic autoinflammatory disorders

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIHISTAMINIC AGENT; CANAKINUMAB; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; SALAZOSULFAPYRIDINE; THALIDOMIDE; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR; BIOLOGICAL PRODUCT; INTERLEUKIN 1 RECEPTOR; NLRP12 PROTEIN, HUMAN; SIGNAL PEPTIDE;

EID: 84881453312     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/939847     Document Type: Review
Times cited : (62)

References (164)
  • 1
    • 84857500409 scopus 로고    scopus 로고
    • The fresco of autoinflammatory diseases from the pediatric perspective
    • 2-s2.0-84857500409 10.1016/j.autrev.2011.10.008
    • Rigante D., The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmunity Reviews 2012 11 5 348 356 2-s2.0-84857500409 10.1016/j.autrev.2011.10.008
    • (2012) Autoimmunity Reviews , vol.11 , Issue.5 , pp. 348-356
    • Rigante, D.1
  • 2
    • 14744296180 scopus 로고    scopus 로고
    • Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: Analysis of 401 cases
    • DOI 10.1111/j.1742-1241.2004.00294.x
    • Sayarlioglu M., Cefle A., Inanc M., Kamali S., Dalkilic E., Gul A., Ocal L., Aral O., Konice M., Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. International Journal of Clinical Practice 2005 59 2 202 205 2-s2.0-14744296180 10.1111/j.1742-1241.2004. 00294.x (Pubitemid 40331221)
    • (2005) International Journal of Clinical Practice , vol.59 , Issue.2 , pp. 202-205
    • Sayarlioglu, M.1    Cefle, A.2    Inanc, M.3    Kamali, S.4    Dalkilic, E.5    Gul, A.6    Ocal, L.7    Aral, O.8    Konice, M.9
  • 4
    • 0036675112 scopus 로고    scopus 로고
    • French Hereditary Recurrent Inflammatory Disorder Study Group. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome
    • 10.1002/art.10429
    • Dodé C., André M., Bienvenu T., French Hereditary Recurrent Inflammatory Disorder Study Group. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism 2002 46 2181 2188 10.1002/art.10429
    • (2002) Arthritis & Rheumatism , vol.46 , pp. 2181-2188
    • Dodé, C.1    André, M.2    Bienvenu, T.3
  • 8
    • 79955566751 scopus 로고    scopus 로고
    • Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes
    • 2-s2.0-79955566751 10.1002/art.30241
    • Jéru I., Le Borgne G., Cochet E., Hayrapetyan H., Duquesnoy P., Grateau G., Morali A., Sarkisian T., Amselem S., Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes. Arthritis & Rheumatism 2011 63 5 1459 1464 2-s2.0-79955566751 10.1002/art.30241
    • (2011) Arthritis & Rheumatism , vol.63 , Issue.5 , pp. 1459-1464
    • Jéru, I.1    Le Borgne, G.2    Cochet, E.3    Hayrapetyan, H.4    Duquesnoy, P.5    Grateau, G.6    Morali, A.7    Sarkisian, T.8    Amselem, S.9
  • 10
    • 22244469461 scopus 로고    scopus 로고
    • Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)
    • DOI 10.1136/jmg.2005.030759
    • Ferguson P. J., Chen S., Tayeh M. K., Ochoa L., Leal S. M., Pelet A., Munnich A., Lyonnet S., Majeed H. A., El-Shanti H., Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). Journal of Medical Genetics 2005 42 7 551 557 2-s2.0-22244469461 10.1136/jmg.2005.030759 (Pubitemid 40993830)
    • (2005) Journal of Medical Genetics , vol.42 , Issue.7 , pp. 551-557
    • Ferguson, P.J.1    Chen, S.2    Tayeh, M.K.3    Ochoa, L.4    Leal, S.M.5    Pelet, A.6    Munnich, A.7    Lyonnet, S.8    Majeed, H.A.9    El-Shanti, H.10
  • 11
    • 33749621794 scopus 로고    scopus 로고
    • Peculiarities of PAPA syndrome
    • DOI 10.1093/rheumatology/kei178
    • Tallon B., Corkill M., Peculiarities of PAPA syndrome. Rheumatology 2006 45 9 1140 1143 2-s2.0-33749621794 10.1093/rheumatology/kei178 (Pubitemid 44542104)
    • (2006) Rheumatology , vol.45 , Issue.9 , pp. 1140-1143
    • Tallon, B.1    Corkill, M.2
  • 15
    • 84866872339 scopus 로고    scopus 로고
    • The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature
    • 10.1016/j.autrev.2012.07.015
    • Muscari I., Iacoponi F., Cantarini L., The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmunity Reviews 2012 12 1 10 13 10.1016/j.autrev.2012.07.015
    • (2012) Autoimmunity Reviews , vol.12 , Issue.1 , pp. 10-13
    • Muscari, I.1    Iacoponi, F.2    Cantarini, L.3
  • 17
    • 84868246282 scopus 로고    scopus 로고
    • Clinical and biochemical landmarks in systemic autoinflammatory diseases
    • 10.3109/07853890.2011.598546
    • Cantarini L., Rigante D., Brizi M. G., Clinical and biochemical landmarks in systemic autoinflammatory diseases. Annals of Medicine 2012 44 664 673 10.3109/07853890.2011.598546
    • (2012) Annals of Medicine , vol.44 , pp. 664-673
    • Cantarini, L.1    Rigante, D.2    Brizi, M.G.3
  • 18
    • 76749139472 scopus 로고    scopus 로고
    • The protean visage of systemic autoinflammatory syndromes: A challenge for inter-professional collaboration
    • 2-s2.0-76749139472
    • Rigante D., The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration. European Review for Medical and Pharmacological Sciences 2010 14 1 1 18 2-s2.0-76749139472
    • (2010) European Review for Medical and Pharmacological Sciences , vol.14 , Issue.1 , pp. 1-18
    • Rigante, D.1
  • 19
    • 11844294692 scopus 로고    scopus 로고
    • Myocarditis and sacroiliitis: 2 Previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome
    • Trost S., Rosé C. D., Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome. Journal of Rheumatology 2005 32 1 175 177 2-s2.0-11844294692 (Pubitemid 40092609)
    • (2005) Journal of Rheumatology , vol.32 , Issue.1 , pp. 175-177
    • Trost, S.1    Rose, C.D.2
  • 21
    • 77956989287 scopus 로고    scopus 로고
    • Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome
    • 2-s2.0-77956989287
    • Cantarini L., Lucherini O. M., Baldari C. T., Laghi Pasini F., Galeazzi M., Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clinical and Experimental Rheumatology 2010 28 3 405 407 2-s2.0-77956989287
    • (2010) Clinical and Experimental Rheumatology , vol.28 , Issue.3 , pp. 405-407
    • Cantarini, L.1    Lucherini, O.M.2    Baldari, C.T.3    Laghi Pasini, F.4    Galeazzi, M.5
  • 23
    • 77949918479 scopus 로고    scopus 로고
    • Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis
    • 2-s2.0-77949918479 10.1016/j.autrev.2009.11.021
    • Cantarini L., Imazio M., Brucato A., Lucherini O. M., Galeazzi M., Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmunity Reviews 2010 9 6 436 440 2-s2.0-77949918479 10.1016/j.autrev.2009.11.021
    • (2010) Autoimmunity Reviews , vol.9 , Issue.6 , pp. 436-440
    • Cantarini, L.1    Imazio, M.2    Brucato, A.3    Lucherini, O.M.4    Galeazzi, M.5
  • 24
    • 77952754400 scopus 로고    scopus 로고
    • Sacroileitis and pericarditis: Atypical presentation of tumour necrosis factor receptor-associated periodic syndrome and response to etanercept therapy
    • 2-s2.0-77952754400
    • Cantarini L., Lucherini O. M., Cimaz R., Baldari C. T., Laghi Pasini F., Galeazzi M., Sacroileitis and pericarditis: atypical presentation of tumour necrosis factor receptor-associated periodic syndrome and response to etanercept therapy. Clinical and Experimental Rheumatology 2010 28 2 290 291 2-s2.0-77952754400
    • (2010) Clinical and Experimental Rheumatology , vol.28 , Issue.2 , pp. 290-291
    • Cantarini, L.1    Lucherini, O.M.2    Cimaz, R.3    Baldari, C.T.4    Laghi Pasini, F.5    Galeazzi, M.6
  • 25
    • 78650552920 scopus 로고    scopus 로고
    • Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment
    • 2-s2.0-78650552920
    • Cantarini L., Lucherini O. M., Cimaz R., Galeazzi M., Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clinical and Experimental Rheumatology 2010 28 5, article 802 2-s2.0-78650552920
    • (2010) Clinical and Experimental Rheumatology , vol.28 , Issue.5 ARTICLE 802
    • Cantarini, L.1    Lucherini, O.M.2    Cimaz, R.3    Galeazzi, M.4
  • 27
    • 37049014725 scopus 로고    scopus 로고
    • Auto inflammatory syndromes: Diagnosis and treatment
    • DOI 10.1016/j.jbspin.2007.07.005, PII S1297319X07002874
    • Stankovic K., Grateau G., Auto inflammatory syndromes: diagnosis and treatment. Joint Bone Spine 2007 74 6 544 550 2-s2.0-37049014725 10.1016/j.jbspin.2007.07.005 (Pubitemid 350245628)
    • (2007) Joint Bone Spine , vol.74 , Issue.6 , pp. 544-550
    • Stankovic, K.1    Grateau, G.2
  • 28
    • 79954513203 scopus 로고    scopus 로고
    • The plodding diagnosis of monogenic autoinflammatory diseases in childhood: From the clinical scenery to laboratory investigation
    • 2-s2.0-79954513203 10.1515/CCLM.2011.127
    • Rigante D., Capoluongo E., The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation. Clinical Chemistry and Laboratory Medicine 2011 49 5 783 791 2-s2.0-79954513203 10.1515/CCLM.2011.127
    • (2011) Clinical Chemistry and Laboratory Medicine , vol.49 , Issue.5 , pp. 783-791
    • Rigante, D.1    Capoluongo, E.2
  • 30
    • 17844377905 scopus 로고    scopus 로고
    • Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: An update
    • DOI 10.2174/1568010053622984
    • Cerquaglia C., Diaco M., Nucera G., La Regina M., Montalto M., Manna R., Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update. Current Drug Targets: Inflammation and Allergy 2005 4 1 117 124 2-s2.0-17844377905 10.2174/1568010053622984 (Pubitemid 40584862)
    • (2005) Current Drug Targets: Inflammation and Allergy , vol.4 , Issue.1 , pp. 117-124
    • Cerquaglia, C.1    Diaco, M.2    Nucera, G.3    La Regina, M.4    Montalto, M.5    Manna, R.6
  • 32
    • 84866840443 scopus 로고    scopus 로고
    • Amyloidosis in autoinflammatory syndromes
    • 10.1016/j.autrev.2012.07.016
    • Obici L., Merlini G., Amyloidosis in autoinflammatory syndromes. Autoimmunity Reviews 2012 12 14 17 10.1016/j.autrev.2012.07.016
    • (2012) Autoimmunity Reviews , vol.12 , pp. 14-17
    • Obici, L.1    Merlini, G.2
  • 33
    • 84867364866 scopus 로고    scopus 로고
    • Autoinflammatory syndromes and cellular responses to stress: Pathophysiology, diagnosis and new treatment perspectives
    • 10.1016/j.berh.2012.07.009
    • Savic S., Dickie L. J., Wittmann M., McDermott M. F., Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Practice & Research Clinical Rheumatology 2012 26 4 505 533 10.1016/j.berh.2012.07.009
    • (2012) Best Practice & Research Clinical Rheumatology , vol.26 , Issue.4 , pp. 505-533
    • Savic, S.1    Dickie, L.J.2    Wittmann, M.3    McDermott, M.F.4
  • 34
    • 84875963811 scopus 로고    scopus 로고
    • Treatment of autoinflammatory diseases: Results from the Eurofever Registry and a literature review
    • 1136/annrheumdis-2011-201268
    • ter Haar N., Lachmann H., Ozen S., Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Annals of the Rheumatic Diseases 2013 72 5 678 685 1136/annrheumdis-2011-201268
    • (2013) Annals of the Rheumatic Diseases , vol.72 , Issue.5 , pp. 678-685
    • Ter Haar, N.1    Lachmann, H.2    Ozen, S.3
  • 35
    • 0015519154 scopus 로고
    • Colchicine for familial Mediterranean fever
    • 2-s2.0-0015519154
    • Goldfinger S. E., Colchicine for familial Mediterranean fever. New England Journal of Medicine 1972 287 25 1302 2-s2.0-0015519154
    • (1972) New England Journal of Medicine , vol.287 , Issue.25 , pp. 1302
    • Goldfinger, S.E.1
  • 36
    • 0141523268 scopus 로고    scopus 로고
    • Familial Mediterranean fever
    • DOI 10.1007/s00467-003-1185-2
    • Bakkaloglu A., Familial Mediterranean fever. Pediatric Nephrology 2003 18 9 853 859 2-s2.0-0141523268 10.1007/s00467-003-1185-2 (Pubitemid 37121615)
    • (2003) Pediatric Nephrology , vol.18 , Issue.9 , pp. 853-859
    • Bakkaloglu, A.1
  • 37
    • 77958163786 scopus 로고    scopus 로고
    • AA type renal amyloidosis secondary to FMF: A long-term follow-up in two patients
    • 2-s2.0-77958163786 10.3109/0886022X.2010.517344
    • Aybal Kutlugun A., Yildirim T., Altindal M., Arici M., Yasavul Ü., Turgan Ç., AA type renal amyloidosis secondary to FMF: a long-term follow-up in two patients. Renal Failure 2010 32 10 1230 1232 2-s2.0-77958163786 10.3109/0886022X.2010.517344
    • (2010) Renal Failure , vol.32 , Issue.10 , pp. 1230-1232
    • Aybal Kutlugun, A.1    Yildirim, T.2    Altindal, M.3    Arici, M.4    Yasavul, Ü.5    Turgan, Ç.6
  • 38
    • 0344897689 scopus 로고    scopus 로고
    • Colchicine treatment in children with familial Mediterranean fever
    • DOI 10.1007/s10067-003-0739-9
    • Ozkaya N., Yalcinkaya F., Colchicine treatment in children with familial Mediterranean fever. Clinical Rheumatology 2003 22 314 317 10.1007/s10067-003- 0739-9 (Pubitemid 37483627)
    • (2003) Clinical Rheumatology , vol.22 , Issue.4-5 , pp. 314-317
    • Ozkaya, N.1    Yalcinkaya, F.2
  • 39
    • 0022570984 scopus 로고
    • Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever
    • Zemer D., Pras M., Sohar E., Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. New England Journal of Medicine 1986 314 16 1001 1005 2-s2.0-0022570984 (Pubitemid 16138694)
    • (1986) New England Journal of Medicine , vol.314 , Issue.16 , pp. 1001-1005
    • Zemer, D.1    Pras, M.2    Sohar, E.3
  • 41
    • 42749097593 scopus 로고    scopus 로고
    • Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion
    • 2-s2.0-42749097593 10.1016/j.jbspin.2007.10.004
    • Erken E., Ozer H. T. E., Bozkurt B., Gunesacar R., Erken E. G., Dinkci S., Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion. Joint Bone Spine 2008 75 3 370 372 2-s2.0-42749097593 10.1016/j.jbspin.2007.10.004
    • (2008) Joint Bone Spine , vol.75 , Issue.3 , pp. 370-372
    • Erken, E.1    Ozer, H.T.E.2    Bozkurt, B.3    Gunesacar, R.4    Erken, E.G.5    Dinkci, S.6
  • 42
    • 0028101194 scopus 로고
    • Protracted febrile myalgia in patients with familial mediterranean fever
    • Langevitz P., Zemer D., Livneh A., Protracted febrile myalgia in patients with familial mediterranean fever. Journal of Rheumatology 1994 21 9 1708 1709 2-s2.0-0028101194 (Pubitemid 24285488)
    • (1994) Journal of Rheumatology , vol.21 , Issue.9 , pp. 1708-1709
    • Langevitz, P.1    Zemer, D.2    Livneh, A.3
  • 43
    • 33750738072 scopus 로고    scopus 로고
    • Treatment options in colchicine resistant familial Mediterranean fever patients: Thalidomide and etanercept as adjunctive agents
    • Seyahi E., Ozdogan H., Celik S., Ugurlu S., Yazici H., Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clinical and Experimental Rheumatology 2006 24 5 S99 S103 2-s2.0-33750738072 (Pubitemid 44696888)
    • (2006) Clinical and Experimental Rheumatology , vol.24 , Issue.5 SUPPL. 42
    • Seyahi, E.1    Ozdogan, H.2    Celik, S.3    Ugurlu, S.4    Yazici, H.5
  • 44
    • 33645733454 scopus 로고    scopus 로고
    • Familial Mediterranean fever responds well to infliximab: Single case experience
    • 2-s2.0-33645733454 10.1007/s10067-005-1122-9
    • Ozgocmen S., Özçakar L., Ardicoglu O., Kocakoc E., Kaya A., Kiris A., Familial Mediterranean fever responds well to infliximab: single case experience. Clinical Rheumatology 2006 25 1 83 87 2-s2.0-33645733454 10.1007/s10067-005-1122-9
    • (2006) Clinical Rheumatology , vol.25 , Issue.1 , pp. 83-87
    • Ozgocmen, S.1    Özçakar, L.2    Ardicoglu, O.3    Kocakoc, E.4    Kaya, A.5    Kiris, A.6
  • 45
    • 34548075550 scopus 로고    scopus 로고
    • Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever
    • DOI 10.2169/internalmedicine.46.0064
    • Nakamura A., Matsuda M., Tazawa K.-I., Shimojima Y., Ikeda S.-I., Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever. Internal Medicine 2007 46 15 1247 1249 2-s2.0-34548075550 10.2169/internalmedicine.46.0064 (Pubitemid 47354446)
    • (2007) Internal Medicine , vol.46 , Issue.15 , pp. 1247-1249
    • Nakamura, A.1    Matsuda, M.2    Tazawa, K.-I.3    Shimojima, Y.4    Ikeda, S.-I.5
  • 46
    • 33846846354 scopus 로고    scopus 로고
    • Familial mediterranean fever successfully treated with etanercept
    • DOI 10.1097/01.rhu.0000255772.25658.7c, PII 0012474320070200000010
    • Mor A., Pillinger M. H., Kishimoto M., Abeles A. M., Livneh A., Familial mediterranean fever successfully treated with etanercept. Journal of Clinical Rheumatology 2007 13 1 38 40 2-s2.0-33846846354 10.1097/01.rhu.0000255772.25658. 7c (Pubitemid 46213843)
    • (2007) Journal of Clinical Rheumatology , vol.13 , Issue.1 , pp. 38-40
    • Mor, A.1    Pillinger, M.H.2    Kishimoto, M.3    Abeles, A.M.4    Livneh, A.5
  • 47
    • 3042592556 scopus 로고    scopus 로고
    • Infliximab treatment of familial Mediterranean fever and its effect on secondary AA amyloidosis
    • DOI 10.1097/01.rhu.0000128856.13595.eb
    • Metyas S., Arkfeld D. G., Forrester D. M., Ehresmann G. R., Infliximab treatment of familial Mediterranean fever and its effect on secondary AA amyloidosis. Journal of Clinical Rheumatology 2004 10 3 134 137 2-s2.0-3042592556 10.1097/01.rhu.0000128856.13595.eb (Pubitemid 38821988)
    • (2004) Journal of Clinical Rheumatology , vol.10 , Issue.3 , pp. 134-137
    • Metyas, S.1    Arkfeld, D.G.2    Forrester, D.M.3    Ehresmann, G.R.4
  • 48
    • 53149122073 scopus 로고    scopus 로고
    • Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy
    • 10.1007/s00296-008-0616-6
    • Bodur H., Seçkin U., Eser F., Ergül G., Seçkin S., Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy. Rheumatology International 2008 29 107 110 10.1007/s00296-008-0616-6
    • (2008) Rheumatology International , vol.29 , pp. 107-110
    • Bodur, H.1    Seçkin, U.2    Eser, F.3    Ergül, G.4    Seçkin, S.5
  • 49
    • 84863532328 scopus 로고    scopus 로고
    • Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: Anti-TNF drugs and FMF
    • 2-s2.0-79952720977 10.1007/s00296-011-1855-5
    • Erten S., Erten S. F., Altunoglu A., Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF. Rheumatology International 2011 32 1095 1097 2-s2.0-79952720977 10.1007/s00296-011-1855-5
    • (2011) Rheumatology International , vol.32 , pp. 1095-1097
    • Erten, S.1    Erten, S.F.2    Altunoglu, A.3
  • 50
    • 84855658573 scopus 로고    scopus 로고
    • Anti-TNF agents in familial Mediterranean fever: Report of three cases and review of the literature
    • 2-s2.0-84855658573 10.1007/s10165-011-0463-2
    • Ozgocmen S., Akgul O., Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. Modern Rheumatology 2011 21 6 684 690 2-s2.0-84855658573 10.1007/s10165-011-0463-2
    • (2011) Modern Rheumatology , vol.21 , Issue.6 , pp. 684-690
    • Ozgocmen, S.1    Akgul, O.2
  • 51
    • 84865966147 scopus 로고    scopus 로고
    • Infliximab therapy for familial Mediterranean fever-related amyloidosis: Case series with long term follow-up
    • Özçakar Z. B., Yüksel S., Ekim M., Yalçnkaya F., Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up. Clinical Rheumatology 2012 31 1267 1271
    • (2012) Clinical Rheumatology , vol.31 , pp. 1267-1271
    • Özçakar, Z.B.1    Yüksel, S.2    Ekim, M.3    Yalçnkaya, F.4
  • 52
    • 84865136977 scopus 로고    scopus 로고
    • An atypical familial Mediterranean fever patient who developed ulcers in the terminal ileum and recurrent abscess-like lesions in multiple organs
    • Takahashi T., Tsukuda H., Itoh H., Kimura H., Yoshimoto M., Tsujisaki M., An atypical familial Mediterranean fever patient who developed ulcers in the terminal ileum and recurrent abscess-like lesions in multiple organs. Internal Medicine 2012 51 2239 2244
    • (2012) Internal Medicine , vol.51 , pp. 2239-2244
    • Takahashi, T.1    Tsukuda, H.2    Itoh, H.3    Kimura, H.4    Yoshimoto, M.5    Tsujisaki, M.6
  • 54
    • 79952425658 scopus 로고    scopus 로고
    • Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine
    • 2-s2.0-79952425658 10.3899/jrheum.100718
    • Özen S., Bilginer Y., Ayaz N. A., Calguneri M., Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. Journal of Rheumatology 2011 38 3 516 518 2-s2.0-79952425658 10.3899/jrheum.100718
    • (2011) Journal of Rheumatology , vol.38 , Issue.3 , pp. 516-518
    • Özen, S.1    Bilginer, Y.2    Ayaz, N.A.3    Calguneri, M.4
  • 56
    • 79955138270 scopus 로고    scopus 로고
    • Interleukin-1 targeting drugs in familial mediterranean fever: A case series and a review of the literature
    • 2-s2.0-79955138270 10.1016/j.semarthrit.2010.11.003
    • Meinzer U., Quartier P., Alexandra J.-F., Hentgen V., Retornaz F., Koné-Paut I., Interleukin-1 targeting drugs in familial mediterranean fever: a case series and a review of the literature. Seminars in Arthritis and Rheumatism 2011 41 2 265 271 2-s2.0-79955138270 10.1016/j.semarthrit.2010.11.003
    • (2011) Seminars in Arthritis and Rheumatism , vol.41 , Issue.2 , pp. 265-271
    • Meinzer, U.1    Quartier, P.2    Alexandra, J.-F.3    Hentgen, V.4    Retornaz, F.5    Koné-Paut, I.6
  • 57
    • 69049085064 scopus 로고    scopus 로고
    • Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
    • 2-s2.0-69049085064 10.1111/j.1365-2141.2009.07733.x
    • Chae J. J., Aksentijevich I., Kastner D. L., Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. British Journal of Haematology 2009 146 5 467 478 2-s2.0-69049085064 10.1111/j.1365-2141.2009.07733.x
    • (2009) British Journal of Haematology , vol.146 , Issue.5 , pp. 467-478
    • Chae, J.J.1    Aksentijevich, I.2    Kastner, D.L.3
  • 59
  • 60
    • 84871914109 scopus 로고    scopus 로고
    • Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure
    • 10.1093/ndt/gfr528
    • Stankovic Stojanovic K., Delmas Y., Torres P. U., Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure. Nephrology Dialysis Transplantation 2012 27 1898 1901 10.1093/ndt/gfr528
    • (2012) Nephrology Dialysis Transplantation , vol.27 , pp. 1898-1901
    • Stankovic Stojanovic, K.1    Delmas, Y.2    Torres, P.U.3
  • 61
    • 77949884645 scopus 로고    scopus 로고
    • Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease
    • 2-s2.0-77949884645 10.1007/s10067-009-1279-8
    • Bilginer Y., Ayaz N. A., Ozen S., Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease. Clinical Rheumatology 2010 29 2 209 210 2-s2.0-77949884645 10.1007/s10067-009-1279-8
    • (2010) Clinical Rheumatology , vol.29 , Issue.2 , pp. 209-210
    • Bilginer, Y.1    Ayaz, N.A.2    Ozen, S.3
  • 62
    • 57849127198 scopus 로고    scopus 로고
    • Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient
    • 2-s2.0-57849127198
    • Mitroulis I., Papadopoulos V. P., Konstantinidis T., Ritis K., Anakinra suppresses familial Mediterranean fever crises in a colchicine-resistant patient. Netherlands Journal of Medicine 2008 66 11 489 491 2-s2.0-57849127198
    • (2008) Netherlands Journal of Medicine , vol.66 , Issue.11 , pp. 489-491
    • Mitroulis, I.1    Papadopoulos, V.P.2    Konstantinidis, T.3    Ritis, K.4
  • 64
    • 35648986741 scopus 로고    scopus 로고
    • Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: Effective but risky
    • DOI 10.1111/j.1365-2362.2007.01868.x
    • Gattringer R., Lagler H., Gattringer K. B., Knapp S., Burgmann H., Winkler S., Graninger W., Thalhammer F., Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky. European Journal of Clinical Investigation 2007 37 11 912 914 2-s2.0-35648986741 10.1111/j.1365-2362.2007.01868.x (Pubitemid 350029205)
    • (2007) European Journal of Clinical Investigation , vol.37 , Issue.11 , pp. 912-914
    • Gattringer, R.1    Lagler, H.2    Gattringer, K.B.3    Knapp, S.4    Burgmann, H.5    Winkler, S.6    Graninger, W.7    Thalhammer, F.8
  • 66
    • 79959246566 scopus 로고    scopus 로고
    • Efficacy of anakinra treatment in a patient with colchicine resistant familial Mediterranean fever
    • 10.1007/s00296-010-1474-6
    • Alpay N., Sumnu A., Calşkan Y., Yazc H., Türkmen A., Gül A., Efficacy of anakinra treatment in a patient with colchicine resistant familial Mediterranean fever. Rheumatology International 2012 32 3277 3279 10.1007/s00296-010-1474-6
    • (2012) Rheumatology International , vol.32 , pp. 3277-3279
    • Alpay, N.1    Sumnu, A.2    Calşkan, Y.3    Yazc, H.4    Türkmen, A.5    Gül, A.6
  • 67
    • 79957663056 scopus 로고    scopus 로고
    • The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis
    • 2-s2.0-79957663056 10.1136/ard.2010.146878
    • Mitroulis I., Skendros P., Oikonomou A., Tzioufas A. G., Ritis K., The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis. Annals of the Rheumatic Diseases 2011 70 7 1347 1348 2-s2.0-79957663056 10.1136/ard.2010. 146878
    • (2011) Annals of the Rheumatic Diseases , vol.70 , Issue.7 , pp. 1347-1348
    • Mitroulis, I.1    Skendros, P.2    Oikonomou, A.3    Tzioufas, A.G.4    Ritis, K.5
  • 68
    • 84861465324 scopus 로고    scopus 로고
    • Canakinumab induces remission in a patient with resistant familial Mediterranean fever
    • article 1041
    • Hacihamdioglu D. O., Ozen S., Canakinumab induces remission in a patient with resistant familial Mediterranean fever. Rheumatology 2012 51 article 1041
    • (2012) Rheumatology , vol.51
    • Hacihamdioglu, D.O.1    Ozen, S.2
  • 69
    • 84868313379 scopus 로고    scopus 로고
    • Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: A randomized trial
    • 10.7326/0003-4819-157-8-201210160-00003
    • Hashkes P. J., Spalding S. J., Giannini E. H., Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Annals of Internal Medicine 2012 157 533 541 10.7326/0003-4819-157-8- 201210160-00003
    • (2012) Annals of Internal Medicine , vol.157 , pp. 533-541
    • Hashkes, P.J.1    Spalding, S.J.2    Giannini, E.H.3
  • 70
    • 0036733312 scopus 로고    scopus 로고
    • The TNF receptor-associated periodic syndrome (TRAPS): Emerging concepts of an autoinflammatory disorder
    • 2-s2.0-0036733312 10.1097/00005792-200209000-00002
    • Hull K. M., Drewe E., Aksentijevich I., Singh H. K., Wong K., McDermott E. M., Dean J., Powell R. J., Kastner D. L., The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 2002 81 5 349 368 2-s2.0-0036733312 10.1097/00005792-200209000-00002
    • (2002) Medicine , vol.81 , Issue.5 , pp. 349-368
    • Hull, K.M.1    Drewe, E.2    Aksentijevich, I.3    Singh, H.K.4    Wong, K.5    McDermott, E.M.6    Dean, J.7    Powell, R.J.8    Kastner, D.L.9
  • 74
    • 29844442446 scopus 로고    scopus 로고
    • Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A
    • DOI 10.1093/rheumatology/kei090
    • Nowlan M. L., Drewe E., Bulsara H., Esposito N., Robins R. A., Tighe P. J., Powell R. J., Todd I., Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A. Rheumatology 2006 45 1 31 37 2-s2.0-29844442446 10.1093/rheumatology/kei090 (Pubitemid 43033871)
    • (2006) Rheumatology , vol.45 , Issue.1 , pp. 31-37
    • Nowlan, M.L.1    Drewe, E.2    Bulsara, H.3    Esposito, N.4    Robins, R.A.5    Tighe, P.J.6    Powell, R.J.7    Todd, I.8
  • 75
    • 50249188364 scopus 로고    scopus 로고
    • Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment
    • 2-s2.0-50249188364 10.1136/ard.2007.079376
    • Stojanov S., Dejaco C., Lohse P., Huss K., Duftner C., Belohradsky B. H., Herold M., Schirmer M., Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Annals of the Rheumatic Diseases 2008 67 9 1292 1298 2-s2.0-50249188364 10.1136/ard.2007.079376
    • (2008) Annals of the Rheumatic Diseases , vol.67 , Issue.9 , pp. 1292-1298
    • Stojanov, S.1    Dejaco, C.2    Lohse, P.3    Huss, K.4    Duftner, C.5    Belohradsky, B.H.6    Herold, M.7    Schirmer, M.8
  • 76
    • 19944429780 scopus 로고    scopus 로고
    • Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response
    • DOI 10.1007/s00431-004-1563-1
    • Aróstegui J. I., Solís P., Aldea A., Cantero T., Rius J., Bahíllo P., Plaza S., Vives J., Gómez S., Yagüe J., Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response. European Journal of Pediatrics 2005 164 1 13 16 2-s2.0-19944429780 10.1007/s00431-004-1563-1 (Pubitemid 40110001)
    • (2005) European Journal of Pediatrics , vol.164 , Issue.1 , pp. 13-16
    • Arostegui, J.I.1    Solis, P.2    Aldea, A.3    Cantero, T.4    Rius, J.5    Bahillo, P.6    Plaza, S.7    Vives, J.8    Gomez, S.9    Yague, J.10
  • 77
    • 84864415897 scopus 로고    scopus 로고
    • Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept
    • 10.1111/j.1442-200X.2011.03525.x
    • Kusuhara K., Hoshina T., Saito M., Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept. Pediatrics International 2012 54 552 555 10.1111/j.1442-200X. 2011.03525.x
    • (2012) Pediatrics International , vol.54 , pp. 552-555
    • Kusuhara, K.1    Hoshina, T.2    Saito, M.3
  • 78
    • 8344258346 scopus 로고    scopus 로고
    • Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome
    • DOI 10.1093/rheumatology/keh357
    • Drewe E., Huggins M. L., Morgan A. G., Cassidy M. J. D., Powell R. J., Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome. Rheumatology 2004 43 11 1405 1408 2-s2.0-8344258346 10.1093/rheumatology/keh357 (Pubitemid 39480929)
    • (2004) Rheumatology , vol.43 , Issue.11 , pp. 1405-1408
    • Drewe, E.1    Huggins, M.L.2    Morgan, A.G.3    Cassidy, M.J.D.4    Powell, R.J.5
  • 79
    • 84857739991 scopus 로고    scopus 로고
    • Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: A prospective, open-label, dose-escalation study
    • 2-s2.0-84857739991 10.1002/art.33416
    • Bulua A. C., Mogul D. B., Aksentijevich I., Singh H., He D. Y., Muenz L. R., Ward M. M., Yarboro C. H., Kastner D. L., Siegel R. M., Hull K. M., Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis & Rheumatism 2012 64 3 908 913 2-s2.0-84857739991 10.1002/art.33416
    • (2012) Arthritis & Rheumatism , vol.64 , Issue.3 , pp. 908-913
    • Bulua, A.C.1    Mogul, D.B.2    Aksentijevich, I.3    Singh, H.4    He, D.Y.5    Muenz, L.R.6    Ward, M.M.7    Yarboro, C.H.8    Kastner, D.L.9    Siegel, R.M.10    Hull, K.M.11
  • 81
    • 36448947978 scopus 로고    scopus 로고
    • Comment on: Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS) [8]
    • DOI 10.1093/rheumatology/kem231
    • Drewe E., Powell R. J., Mcdermott E. M., Comment on: failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology 2007 46 12 1865 1866 2-s2.0-36448947978 10.1093/rheumatology/kem231 (Pubitemid 350168311)
    • (2007) Rheumatology , vol.46 , Issue.12 , pp. 1865-1866
    • Drewe, E.1    Powell, R.J.2    Mcdermott, E.M.3
  • 82
    • 34447308222 scopus 로고    scopus 로고
    • Failure of anti-TNF therapy in TNF receptor 1 - Associated Periodic Syndrome (TRAPS) [5]
    • DOI 10.1093/rheumatology/kel298
    • Jacobelli S., André M., Alexandra J.-F., Dodé C., Papo T., Failure of anti-TNF therapy in TNF receptor 1-associated Periodic Syndrome (TRAPS). Rheumatology 2007 46 7 1211 1212 2-s2.0-34447308222 10.1093/rheumatology/kel298 (Pubitemid 47050633)
    • (2007) Rheumatology , vol.46 , Issue.7 , pp. 1211-1212
    • Jacobelli, S.1    Andre, M.2    Alexandra, J.-F.3    Dode, C.4    Papo, T.5
  • 83
    • 33744762863 scopus 로고    scopus 로고
    • Hereditary auto-inflammatory disorders and biologics
    • DOI 10.1007/s00281-006-0015-6
    • Church L. D., Churchman S. M., Hawkins P. N., McDermott M. F., Hereditary auto-inflammatory disorders and biologics. Springer Seminars in Immunopathology 2006 27 4 494 508 2-s2.0-33744762863 10.1007/s00281-006-0015-6 (Pubitemid 43825168)
    • (2006) Springer Seminars in Immunopathology , vol.27 , Issue.4 , pp. 494-508
    • Church, L.D.1    Churchman, S.M.2    Hawkins, P.N.3    McDermott, M.F.4
  • 84
    • 59649101629 scopus 로고    scopus 로고
    • Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome
    • 2-s2.0-59649101629 10.1002/art.24294
    • Nedjai B., Hitman G. A., Quillinan N., Coughlan R. J., Church L., McDermott M. F., Turner M. D., Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism 2009 60 2 619 625 2-s2.0-59649101629 10.1002/art.24294
    • (2009) Arthritis & Rheumatism , vol.60 , Issue.2 , pp. 619-625
    • Nedjai, B.1    Hitman, G.A.2    Quillinan, N.3    Coughlan, R.J.4    Church, L.5    McDermott, M.F.6    Turner, M.D.7
  • 86
    • 79959793377 scopus 로고    scopus 로고
    • Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis
    • 2-s2.0-79959793377 10.1136/ard.2010.143438
    • Obici L., Meini A., Cattalini M., Chicca S., Galliani M., Donadei S., Plebani A., Merlini G., Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. Annals of the Rheumatic Diseases 2011 70 8 1511 1512 2-s2.0-79959793377 10.1136/ard.2010.143438
    • (2011) Annals of the Rheumatic Diseases , vol.70 , Issue.8 , pp. 1511-1512
    • Obici, L.1    Meini, A.2    Cattalini, M.3    Chicca, S.4    Galliani, M.5    Donadei, S.6    Plebani, A.7    Merlini, G.8
  • 87
    • 80051473290 scopus 로고    scopus 로고
    • Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome
    • 2-s2.0-80051473290 10.1136/ard.2010.144279
    • Quillinan N., Mannion G., Mohammad A., Coughlan R., Dickie L. J., McDermott M. F., McGonagle D., Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome. Annals of the Rheumatic Diseases 2011 70 9 1692 1693 2-s2.0-80051473290 10.1136/ard.2010.144279
    • (2011) Annals of the Rheumatic Diseases , vol.70 , Issue.9 , pp. 1692-1693
    • Quillinan, N.1    Mannion, G.2    Mohammad, A.3    Coughlan, R.4    Dickie, L.J.5    McDermott, M.F.6    McGonagle, D.7
  • 88
    • 84862731000 scopus 로고    scopus 로고
    • Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab
    • 10.7326/0003-4819-156-12-201206190-00027
    • Brizi M. G., Galeazzi M., Lucherini O. M., Cantarini L., Cimaz R., Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab. Annals of Internal Medicine 2012 156 12 907 908 10.7326/0003-4819-156-12-201206190-00027
    • (2012) Annals of Internal Medicine , vol.156 , Issue.12 , pp. 907-908
    • Brizi, M.G.1    Galeazzi, M.2    Lucherini, O.M.3    Cantarini, L.4    Cimaz, R.5
  • 89
    • 84886783036 scopus 로고    scopus 로고
    • Efficacy and safety of canakinumab in patients with TNF receptor associated periodic syndrome
    • supplement 3, article 289
    • Gattorno M., Obici L., Meini A., Efficacy and safety of canakinumab in patients with TNF receptor associated periodic syndrome. Annals of the Rheumatic Diseases 2012 71 supplement 3, article 289
    • (2012) Annals of the Rheumatic Diseases , vol.71
    • Gattorno, M.1    Obici, L.2    Meini, A.3
  • 90
    • 79953689919 scopus 로고    scopus 로고
    • Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome
    • 2-s2.0-79953689919 10.1002/art.30215
    • Vaitla P. M., Radford P. M., Tighe P. J., Powell R. J., McDermott E. M., Todd I., Drewe E., Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome. Arthritis & Rheumatism 2011 63 4 1151 1155 2-s2.0-79953689919 10.1002/art.30215
    • (2011) Arthritis & Rheumatism , vol.63 , Issue.4 , pp. 1151-1155
    • Vaitla, P.M.1    Radford, P.M.2    Tighe, P.J.3    Powell, R.J.4    McDermott, E.M.5    Todd, I.6    Drewe, E.7
  • 91
    • 33845686908 scopus 로고    scopus 로고
    • Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations
    • DOI 10.1001/archderm.142.12.1591
    • Leslie K. S., Lachmann H. J., Bruning E., McGrath J. A., Bybee A., Gallimore J. R., Roberts P. F., Woo P., Grattan C. E., Hawkins P. N., Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Archives of Dermatology 2006 142 12 1591 1597 2-s2.0-33845686908 10.1001/archderm.142.12. 1591 (Pubitemid 44969215)
    • (2006) Archives of Dermatology , vol.142 , Issue.12 , pp. 1591-1597
    • Leslie, K.S.1    Lachmann, H.J.2    Bruning, E.3    McGrath, J.A.4    Bybee, A.5    Gallimore, J.R.6    Roberts, P.F.7    Woo, P.8    Grattan, C.E.9    Hawkins, P.N.10
  • 92
    • 1642285783 scopus 로고    scopus 로고
    • NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
    • DOI 10.1016/S1074-7613(04)00046-9, PII S1074761304000469
    • Agostini L., Martinon F., Burns K., McDermott M. F., Hawkins P. N., Tschopp J., NALP3 forms an IL-1 β -processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004 20 3 319 325 2-s2.0-1642285783 10.1016/S1074-7613(04)00046-9 (Pubitemid 38388233)
    • (2004) Immunity , vol.20 , Issue.3 , pp. 319-325
    • Agostini, L.1    Martinon, F.2    Burns, K.3    McDermott, M.F.4    Hawkins, P.N.5    Tschopp, J.6
  • 94
    • 0035822274 scopus 로고    scopus 로고
    • Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
    • DOI 10.1016/S0140-6736(00)05252-1
    • Gillmore J. D., Lovat L. B., Persey M. R., Pepys M. B., Hawkins P. N., Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001 358 9275 24 29 2-s2.0-0035822274 10.1016/S0140-6736(00)05252-1 (Pubitemid 32709735)
    • (2001) Lancet , vol.358 , Issue.9275 , pp. 24-29
    • Gillmore, J.D.1    Lovat, L.B.2    Persey, M.R.3    Pepys, M.B.4    Hawkins, P.N.5
  • 95
    • 0037792866 scopus 로고    scopus 로고
    • Interleukin-1-receptor antagonist in the Muckle-Wells syndrome [8]
    • DOI 10.1056/NEJM200306193482523
    • Hawkins P. N., Lachmann H. J., McDermott M. F., Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. New England Journal of Medicine 2003 348 25 2583 2584 2-s2.0-0037792866 10.1056/NEJM200306193482523 (Pubitemid 36706554)
    • (2003) New England Journal of Medicine , vol.348 , Issue.25 , pp. 2583-2584
    • Hawkins, P.N.1    Lachmann, H.J.2    McDermott, M.F.3
  • 96
    • 8444225132 scopus 로고    scopus 로고
    • Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist
    • DOI 10.1016/S0140-6736(04)17401-1, PII S0140673604174011
    • Hoffman H. M., Rosengren S., Boyle D. L., Cho J. Y., Nayar J., Mueller J. L., Anderson J. P., Wanderer A. A., Firestein G. S., Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. The Lancet 2004 364 9447 1779 1785 2-s2.0-8444225132 10.1016/S0140-6736(04)17401-1 (Pubitemid 39488063)
    • (2004) Lancet , vol.364 , Issue.9447 , pp. 1779-1785
    • Hoffman, H.M.1    Rosengren, S.2    Boyle, D.L.3    Cho, J.Y.4    Nayar, J.5    Mueller, J.L.6    Anderson, J.P.7    Wanderer, A.A.8    Firestein, G.S.9
  • 97
    • 24944528385 scopus 로고    scopus 로고
    • Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS) [4]
    • DOI 10.1093/rheumatology/keh652
    • Ramos E., Aróstegui J. I., Campuzano S., Rius J., Bousoño C., Yagüe J., Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology 2005 44 8 1072 1073 2-s2.0-24944528385 10.1093/rheumatology/keh652 (Pubitemid 41487188)
    • (2005) Rheumatology , vol.44 , Issue.8 , pp. 1072-1073
    • Ramos, E.1    Arostegui, J.I.2    Campuzano, S.3    Rius, J.4    Bousono, C.5    Yague, J.6
  • 98
  • 99
    • 33645561945 scopus 로고    scopus 로고
    • Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment
    • 2-s2.0-33645561945 10.1002/ajmg.a.31148
    • Boschan C., Witt O., Lohse P., Foeldvari I., Zappel H., Schweigerer L., Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. American Journal of Medical Genetics 2006 140 8 883 886 2-s2.0-33645561945 10.1002/ajmg.a.31148
    • (2006) American Journal of Medical Genetics , vol.140 , Issue.8 , pp. 883-886
    • Boschan, C.1    Witt, O.2    Lohse, P.3    Foeldvari, I.4    Zappel, H.5    Schweigerer, L.6
  • 101
    • 83555160888 scopus 로고    scopus 로고
    • Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA)
    • 2-s2.0-83555160888 10.1007/s00296-010-1787-5
    • Rigante D., Leone A., Marrocco R., Laino M. E., Stabile A., Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA). Rheumatology International 2011 31 12 1661 1664 2-s2.0-83555160888 10.1007/s00296-010-1787-5
    • (2011) Rheumatology International , vol.31 , Issue.12 , pp. 1661-1664
    • Rigante, D.1    Leone, A.2    Marrocco, R.3    Laino, M.E.4    Stabile, A.5
  • 106
    • 84855796483 scopus 로고    scopus 로고
    • Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: Results of a double-blind placebo-controlled randomized withdrawal study
    • 2-s2.0-84855796483 10.1186/ar3535
    • Koné-Paut I., Lachmann H. J., Kuemmerle-Deschner J. B., Hachulla E., Leslie K. S., Mouy R., Ferreira A., Lheritier K., Patel N., Preiss R., Hawkins P. N., Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: Results of a double-blind placebo-controlled randomized withdrawal study. Arthritis Research and Therapy 2011 13 6, article R202 2-s2.0-84855796483 10.1186/ar3535
    • (2011) Arthritis Research and Therapy , vol.13 , Issue.6 ARTICLE R202
    • Koné-Paut, I.1    Lachmann, H.J.2    Kuemmerle-Deschner, J.B.3    Hachulla, E.4    Leslie, K.S.5    Mouy, R.6    Ferreira, A.7    Lheritier, K.8    Patel, N.9    Preiss, R.10    Hawkins, P.N.11
  • 107
    • 84875796225 scopus 로고    scopus 로고
    • Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results)
    • Imagawa T., Nishikomori R., Takada H., Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results). Clinical and Experimental Rheumatology 2013 31 302 309
    • (2013) Clinical and Experimental Rheumatology , vol.31 , pp. 302-309
    • Imagawa, T.1    Nishikomori, R.2    Takada, H.3
  • 109
    • 49449094179 scopus 로고    scopus 로고
    • Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies
    • 2-s2.0-49449094179 10.1002/art.23687
    • Hoffman H. M., Throne M. L., Amar N. J., Sebai M., Kivitz A. J., Kavanaugh A., Weinstein S. P., Belomestnov P., Yancopoulos G. D., Stahl N., Mellis S. J., Efficacy and safety of rilonacept (Interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis & Rheumatism 2008 58 8 2443 2452 2-s2.0-49449094179 10.1002/art.23687
    • (2008) Arthritis & Rheumatism , vol.58 , Issue.8 , pp. 2443-2452
    • Hoffman, H.M.1    Throne, M.L.2    Amar, N.J.3    Sebai, M.4    Kivitz, A.J.5    Kavanaugh, A.6    Weinstein, S.P.7    Belomestnov, P.8    Yancopoulos, G.D.9    Stahl, N.10    Mellis, S.J.11
  • 110
    • 84867377973 scopus 로고    scopus 로고
    • Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: Results of a 72-week open-label extension study
    • 10.1016/j.clinthera.2012.09.009
    • Hoffman H. M., Throne M. L., Amar N. J., Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study. Clinical Therapeutics 2012 34 2091 2103 10.1016/j.clinthera.2012.09.009
    • (2012) Clinical Therapeutics , vol.34 , pp. 2091-2103
    • Hoffman, H.M.1    Throne, M.L.2    Amar, N.J.3
  • 112
    • 58149195381 scopus 로고    scopus 로고
    • Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome
    • 2-s2.0-58149195381 10.1097/MD.0b013e318190cfb7
    • van der Hilst J. C. H., Bodar E. J., Barron K. S., Frenkel J., Drenth J. P. H., van der Meer J. W. M., Simon A., Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine 2008 87 6 301 310 2-s2.0-58149195381 10.1097/MD. 0b013e318190cfb7
    • (2008) Medicine , vol.87 , Issue.6 , pp. 301-310
    • Van Der Hilst, J.C.H.1    Bodar, E.J.2    Barron, K.S.3    Frenkel, J.4    Drenth, J.P.H.5    Van Der Meer, J.W.M.6    Simon, A.7
  • 113
    • 2042501706 scopus 로고    scopus 로고
    • Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome
    • DOI 10.1016/j.clpt.2004.01.012, PII S0009923604000372
    • Simon A., Drewe E., van der Meer J. W. M., Powell R. J., Kelley R. I., Stalenhoef A. F. H., Drenth J. P. H., Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clinical Pharmacology and Therapeutics 2004 75 5 476 483 2-s2.0-2042501706 10.1016/j.clpt.2004.01.012 (Pubitemid 38534568)
    • (2004) Clinical Pharmacology and Therapeutics , vol.75 , Issue.5 , pp. 476-483
    • Simon, A.1    Drewe, E.2    Van Der Meer, J.W.M.3    Powell, R.J.4    Kelley, R.I.5    Stalenhoef, A.F.H.6    Drenth, J.P.H.7
  • 114
    • 0029009413 scopus 로고
    • Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome
    • 2-s2.0-0029009413
    • Drenth J. P. H., van Deuren M., van der Ven-Jongekrijg J., Schalkwijk C. G., van der Meer J. W. M., Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 1995 85 12 3586 3593 2-s2.0-0029009413
    • (1995) Blood , vol.85 , Issue.12 , pp. 3586-3593
    • Drenth, J.P.H.1    Van Deuren, M.2    Van Der Ven-Jongekrijg, J.3    Schalkwijk, C.G.4    Van Der Meer, J.W.M.5
  • 117
    • 33750489045 scopus 로고    scopus 로고
    • Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome
    • DOI 10.1007/s00296-006-0164-x
    • Rigante D., Ansuini V., Bertoni B., Pugliese A. L., Avallone L., Federico G., Stabile A., Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome. Rheumatology International 2006 27 1 97 100 2-s2.0-33750489045 10.1007/s00296-006-0164-x (Pubitemid 44655757)
    • (2006) Rheumatology International , vol.27 , Issue.1 , pp. 97-100
    • Rigante, D.1    Ansuini, V.2    Bertoni, B.3    Pugliese, A.L.4    Avallone, L.5    Federico, G.6    Stabile, A.7
  • 118
    • 78650092436 scopus 로고    scopus 로고
    • Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report
    • 2-s2.0-78650092436 10.1111/j.1651-2227.2010.01974.x
    • Korppi M., van Gijn M. E., Antila K., Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report. Acta Paediatrica, International Journal of Paediatrics 2011 100 1 21 25 2-s2.0-78650092436 10.1111/j.1651-2227.2010.01974.x
    • (2011) Acta Paediatrica, International Journal of Paediatrics , vol.100 , Issue.1 , pp. 21-25
    • Korppi, M.1    Van Gijn, M.E.2    Antila, K.3
  • 119
    • 84867131436 scopus 로고    scopus 로고
    • Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
    • Galeotti C., Meinzer U., Quartier P., Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatology (Oxford) 2012 51 1855 1859
    • (2012) Rheumatology (Oxford) , vol.51 , pp. 1855-1859
    • Galeotti, C.1    Meinzer, U.2    Quartier, P.3
  • 120
    • 84860389029 scopus 로고    scopus 로고
    • On-demand anakinra treatment is effective in mevalonate kinase deficiency
    • 2-s2.0-84860389029 10.1136/ard.2011.149922
    • Bodar E. J., Kuijk L. M., Drenth J. P. H., Van Der Meer J. W. M., Simon A., Frenkel J., On-demand anakinra treatment is effective in mevalonate kinase deficiency. Annals of the Rheumatic Diseases 2011 70 12 2155 2158 2-s2.0-84860389029 10.1136/ard.2011.149922
    • (2011) Annals of the Rheumatic Diseases , vol.70 , Issue.12 , pp. 2155-2158
    • Bodar, E.J.1    Kuijk, L.M.2    Drenth, J.P.H.3    Van Der Meer, J.W.M.4    Simon, A.5    Frenkel, J.6
  • 121
    • 51549087763 scopus 로고    scopus 로고
    • Hyperimmunoglobulinemia D and periodic fever syndrome; Treatment with etanercept and follow-up
    • 2-s2.0-51549087763 10.1007/s10067-008-0911-3
    • Topalolu R., Ayaz N. A., Waterham H. R., Yüce A., Gumruk F., Sanal Ö., Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clinical Rheumatology 2008 27 10 1317 1320 2-s2.0-51549087763 10.1007/s10067-008-0911-3
    • (2008) Clinical Rheumatology , vol.27 , Issue.10 , pp. 1317-1320
    • Topalolu, R.1    Ayaz, N.A.2    Waterham, H.R.3    Yüce, A.4    Gumruk, F.5    Sanal, Ö.6
  • 122
    • 0141453408 scopus 로고    scopus 로고
    • Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome
    • DOI 10.1002/art.11218
    • Takada K., Aksentijevich I., Mahadevan V., Dean J. A., Kelley R. I., Kastner D. L., Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis & Rheumatism 2003 48 9 2645 2651 2-s2.0-0141453408 10.1002/art.11218 (Pubitemid 37129442)
    • (2003) Arthritis and Rheumatism , vol.48 , Issue.9 , pp. 2645-2651
    • Takada, K.1    Aksentijevich, I.2    Mahadevan, V.3    Dean, J.A.4    Kelley, R.I.5    Kastner, D.L.6
  • 123
    • 69349102906 scopus 로고    scopus 로고
    • Nummular keratopathy in a patient with Hyper-IgD Syndrome
    • 2-s2.0-69349102906 10.1186/1546-0096-7-14
    • Kraus C. L., Culican S. M., Nummular keratopathy in a patient with Hyper-IgD Syndrome. Pediatric Rheumatology 2009 7, article 14 2-s2.0-69349102906 10.1186/1546-0096-7-14
    • (2009) Pediatric Rheumatology , vol.714
    • Kraus, C.L.1    Culican, S.M.2
  • 124
    • 84857115753 scopus 로고    scopus 로고
    • Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome
    • 2-s2.0-84857115753 10.1007/s00296-009-1322-8
    • Shendi H. M., Walsh D., Edgar J. D. M., Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatology International 2012 32 1 249 251 2-s2.0-84857115753 10.1007/s00296-009-1322-8
    • (2012) Rheumatology International , vol.32 , Issue.1 , pp. 249-251
    • Shendi, H.M.1    Walsh, D.2    Edgar, J.D.M.3
  • 127
    • 79959840140 scopus 로고    scopus 로고
    • Role of interleukin-1 β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy
    • 2-s2.0-79959840140 10.1002/art.30378
    • Jéru I., Hentgen V., Normand S., Duquesnoy P., Cochet E., Delwail A., Grateau G., Marlin S., Amselem S., Lecron J.-C., Role of interleukin-1 β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy. Arthritis & Rheumatism 2011 63 7 2142 2148 2-s2.0-79959840140 10.1002/art.30378
    • (2011) Arthritis & Rheumatism , vol.63 , Issue.7 , pp. 2142-2148
    • Jéru, I.1    Hentgen, V.2    Normand, S.3    Duquesnoy, P.4    Cochet, E.5    Delwail, A.6    Grateau, G.7    Marlin, S.8    Amselem, S.9    Lecron, J.-C.10
  • 128
    • 0141747229 scopus 로고    scopus 로고
    • Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation
    • DOI 10.1016/S0161-6420(03)00717-6
    • Kurokawa T., Kikuchi T., Ohta K., Imai H., Yoshimura N., Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology 2003 110 10 2040 2044 2-s2.0-0141747229 10.1016/S0161-6420(03) 00717-6 (Pubitemid 37163327)
    • (2003) Ophthalmology , vol.110 , Issue.10 , pp. 2040-2044
    • Kurokawa, T.1    Kikuchi, T.2    Ohta, K.3    Imai, H.4    Yoshimura, N.5
  • 129
    • 0022213722 scopus 로고
    • Familial granulomatous arthritis, iritis, and rash
    • DOI 10.1016/S0022-3476(85)80394-2
    • Blau E. B., Familial granulomatous arthritis, iritis, and rash. Journal of Pediatrics 1985 107 5 689 693 2-s2.0-0022213722 (Pubitemid 16250502)
    • (1985) Journal of Pediatrics , vol.107 , Issue.5 , pp. 689-693
    • Blau, E.B.1
  • 130
    • 58149474704 scopus 로고    scopus 로고
    • Clinical and genetic aspects of Blau syndrome: A 25-year follow-up of one family and a literature review
    • 2-s2.0-58149474704 10.1016/j.autrev.2008.07.034
    • Punzi L., Furlan A., Podswiadek M., Gava A., Valente M., De Marchi M., Peserico A., Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmunity Reviews 2009 8 3 228 232 2-s2.0-58149474704 10.1016/j.autrev.2008.07.034
    • (2009) Autoimmunity Reviews , vol.8 , Issue.3 , pp. 228-232
    • Punzi, L.1    Furlan, A.2    Podswiadek, M.3    Gava, A.4    Valente, M.5    De Marchi, M.6    Peserico, A.7
  • 132
    • 1342310827 scopus 로고    scopus 로고
    • Bupropion for Blau syndrome
    • DOI 10.1016/S0306-9877(03)00334-7
    • Altschuler E. L., Kast R. E., Bupropion for Blau syndrome. Medical Hypotheses 2004 62 2 297 298 2-s2.0-1342310827 10.1016/S0306-9877(03)00334-7 (Pubitemid 38253400)
    • (2004) Medical Hypotheses , vol.62 , Issue.2 , pp. 297-298
    • Altschuler, E.L.1    Kast, R.E.2
  • 133
    • 33845707639 scopus 로고    scopus 로고
    • Favourable effect of TNF-α inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation
    • DOI 10.1111/j.1600-0463.2006.apm-522.x
    • Milman N., Andersen C. B., Hansen A., Van Overeem Hansen T., Nielsen F. C., Fledelius H., Ahrens P., Nielsen O. H., Favourable effect of TNF- α inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 2006 114 12 912 919 2-s2.0-33845707639 10.1111/j.1600-0463.2006.apm-522.x (Pubitemid 44967328)
    • (2006) APMIS , vol.114 , Issue.12 , pp. 912-919
    • Milman, N.1    Andersen, C.B.2    Hansen, A.3    Van Overeem Hansen, T.4    Nielsen, F.C.5    Fledelius, H.6    Ahrens, P.7    Nielsen, O.H.8
  • 134
    • 79956218796 scopus 로고    scopus 로고
    • Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene
    • 2-s2.0-79956218796 10.1016/j.jaapos.2011.02.004
    • Raiji V. R., Miller M. M., Jung L. K., Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene. Journal of AAPOS 2011 15 2 205 207 2-s2.0-79956218796 10.1016/j.jaapos.2011.02.004
    • (2011) Journal of AAPOS , vol.15 , Issue.2 , pp. 205-207
    • Raiji, V.R.1    Miller, M.M.2    Jung, L.K.3
  • 135
  • 137
    • 0034006361 scopus 로고    scopus 로고
    • Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an African-American family
    • Cuesta I. A., Moore E. C., Rabah R., Bawle E. V., Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an African-American family. Journal of Clinical Rheumatology 2000 6 1 30 34 2-s2.0-0034006361 (Pubitemid 30127493)
    • (2000) Journal of Clinical Rheumatology , vol.6 , Issue.1 , pp. 30-34
    • Cuesta, I.A.1    Moore, E.C.2    Rabah, R.3    Bawle, E.V.4
  • 138
    • 79955134669 scopus 로고    scopus 로고
    • Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNF- α monoclonal antibodies
    • 2-s2.0-79955134669 10.1093/rheumatology/keq431
    • Sharma S. M., Martin T. M., Rosé C. D., Dick A. D., Ramanan A. V., Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNF- α monoclonal antibodies. Rheumatology 2011 50 5 990 992 2-s2.0-79955134669 10.1093/rheumatology/keq431
    • (2011) Rheumatology , vol.50 , Issue.5 , pp. 990-992
    • Sharma, S.M.1    Martin, T.M.2    Rosé, C.D.3    Dick, A.D.4    Ramanan, A.V.5
  • 139
    • 36048981805 scopus 로고    scopus 로고
    • NOD2 gene-associated pediatric granulomatous arthritis: Clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort
    • DOI 10.1002/art.22966
    • Aróstegui J. I., Arnal C., Merino R., Modesto C., Carballo M. A., Moreno P., García-Consuegra J., Naranjo A., Ramos E., De Paz P., Rius J., Plaza S., Yagüe J., NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis & Rheumatism 2007 56 11 3805 3813 2-s2.0-36048981805 10.1002/art.22966 (Pubitemid 350100713)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.11 , pp. 3805-3813
    • Arostegui, J.I.1    Arnal, C.2    Merino, R.3    Modesto, C.4    Carballo, M.A.5    Moreno, P.6    Garcia-Consuegra, J.7    Naranjo, A.8    Ramos, E.9    De Paz, P.10    Rius, J.11    Plaza, S.12    Yague, J.13
  • 140
    • 84873814538 scopus 로고    scopus 로고
    • Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis
    • 10.1002/art.37776
    • Simonini G., Xu Z., Caputo R., Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis & Rheumatism 2013 65 2 513 518 10.1002/art.37776
    • (2013) Arthritis & Rheumatism , vol.65 , Issue.2 , pp. 513-518
    • Simonini, G.1    Xu, Z.2    Caputo, R.3
  • 141
    • 74849116666 scopus 로고    scopus 로고
    • Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/blau syndrome: Its possible action and mechanism
    • 2-s2.0-74849116666 10.1002/art.25035
    • Yasui K., Yashiro M., Tsuge M., Manki A., Takemoto K., Yamamoto M., Morishima T., Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/blau syndrome: its possible action and mechanism. Arthritis & Rheumatism 2010 62 1 250 257 2-s2.0-74849116666 10.1002/art.25035
    • (2010) Arthritis & Rheumatism , vol.62 , Issue.1 , pp. 250-257
    • Yasui, K.1    Yashiro, M.2    Tsuge, M.3    Manki, A.4    Takemoto, K.5    Yamamoto, M.6    Morishima, T.7
  • 142
    • 0024466508 scopus 로고
    • Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings
    • Majeed H. A., Kalaawi M., Mohanty D., Teebi A. S., Tunjekar M. F., Al-Gharbawy F., Majeed S. A., Al-Gazzar A. H., Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. Journal of Pediatrics 1989 115 5 730 734 2-s2.0-0024466508 (Pubitemid 19270263)
    • (1989) Journal of Pediatrics , vol.115 , Issue.5 I , pp. 730-734
    • Majeed, H.A.1    Kalaawi, M.2    Mohanty, D.3    Teebi, A.S.4    Tunjekar, M.F.5    Al-Gharbawy, F.6    Majeed, S.A.7    Al-Gazzar, A.H.8
  • 143
    • 0035213576 scopus 로고    scopus 로고
    • The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review
    • Majeed H. A., Al-Tarawna M., El-Shanti H., Kamel B., Al-Khalaileh F., The syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia. Report of a new family and a review. European Journal of Pediatrics 2001 160 12 705 710 2-s2.0-0035213576 (Pubitemid 33139883)
    • (2001) European Journal of Pediatrics , vol.160 , Issue.12 , pp. 705-710
    • Majeed, H.A.1    Al-Tarawna, M.2    El-Shanti, H.3    Kamel, B.4    Al-Khalaileh, F.5
  • 144
    • 0033831130 scopus 로고    scopus 로고
    • On mice and men: An autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia
    • 2-s2.0-0033831130
    • Majeed H. A., El-Shanti H., Al-Rimawi H., Al-Masri N., On mice and men: an autosomal recessive syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia. Journal of Pediatrics 2000 137 3 441 442 2-s2.0-0033831130
    • (2000) Journal of Pediatrics , vol.137 , Issue.3 , pp. 441-442
    • Majeed, H.A.1    El-Shanti, H.2    Al-Rimawi, H.3    Al-Masri, N.4
  • 145
    • 33947137738 scopus 로고    scopus 로고
    • A splice site mutation confirms the role of LPIN2 in Majeed syndrome
    • DOI 10.1002/art.22431
    • Al-Mosawi Z. S., Al-Saad K. K., Ijadi-Maghsoodi R., El-Shanti H. I., Ferguson P. J., A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis & Rheumatism 2007 56 3 960 964 2-s2.0-33947137738 10.1002/art.22431 (Pubitemid 46399443)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.3 , pp. 960-964
    • Al-Mosawi, Z.S.1    Al-Saad, K.K.2    Ijadi-Maghsoodi, R.3    El-Shanti, H.I.4    Ferguson, P.J.5
  • 146
    • 84873726217 scopus 로고    scopus 로고
    • Efficacy of anti-IL-1 treatment in Majeed syndrome
    • 10.1136/annrheumdis-2012-201818
    • Herlin T., Fiirgaard B., Bjerre M., Efficacy of anti-IL-1 treatment in Majeed syndrome. Annals of the Rheumatic Diseases 2013 72 410 413 10.1136/annrheumdis-2012-201818
    • (2013) Annals of the Rheumatic Diseases , vol.72 , pp. 410-413
    • Herlin, T.1    Fiirgaard, B.2    Bjerre, M.3
  • 147
    • 0030804743 scopus 로고    scopus 로고
    • A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome
    • Llndor N. M., Arsenault T. M., Solomon H., Seidman C. E., McEvov M. T., A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clinic Proceedings 1997 72 7 611 615 2-s2.0-0030804743 (Pubitemid 27330245)
    • (1997) Mayo Clinic Proceedings , vol.72 , Issue.7 , pp. 611-615
    • Llndor, N.M.1    Arsenault, T.M.2    Solomon, H.3    Seidman, C.E.4    McEvov, M.T.5
  • 148
    • 84861808859 scopus 로고    scopus 로고
    • Brief report: Genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)
    • 10.1002/art.34332
    • Demidowich A. P., Freeman A. F., Kuhns D. B., Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne). Arthritis & Rheumatism 2012 64 6 2022 2027 10.1002/art.34332
    • (2012) Arthritis & Rheumatism , vol.64 , Issue.6 , pp. 2022-2027
    • Demidowich, A.P.1    Freeman, A.F.2    Kuhns, D.B.3
  • 149
    • 19644375183 scopus 로고    scopus 로고
    • Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome
    • DOI 10.1111/j.1525-1470.2005.22320.x
    • Stichweh D. S., Punaro M., Pascual V., Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatric Dermatology 2005 22 3 262 265 2-s2.0-19644375183 10.1111/j.1525-1470.2005.22320. x (Pubitemid 40741268)
    • (2005) Pediatric Dermatology , vol.22 , Issue.3 , pp. 262-265
    • Stichweh, D.S.1    Punaro, M.2    Pascual, V.3
  • 150
    • 9744236591 scopus 로고    scopus 로고
    • Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome
    • DOI 10.1016/j.jpeds.2004.08.001, PII S0022347604007140
    • Cortis E., de Benedetti F., Insalaco A., Cioschi S., Muratori F., D'Urbano L. E., Ugazio A. G., Abnormal production of the tumor necrosis factor inhibitor etanercept and clinical efficacy of tumor in a patient with PAPA syndrome. Journal of Pediatrics 2004 145 6 851 855 2-s2.0-9744236591 10.1016/j.jpeds.2004.08.001 (Pubitemid 39586631)
    • (2004) Journal of Pediatrics , vol.145 , Issue.6 , pp. 851-855
    • Cortis, E.1    De Benedetti, F.2    Insalaco, A.3    Cioschi, S.4    Muratori, F.5    D'Urbano, L.E.6    Ugazio, A.G.7
  • 151
    • 77955200312 scopus 로고    scopus 로고
    • Clinical efficacy of etanercept for treatment of PAPA syndrome
    • 10.1097/RHU.0b013e3181e969b9
    • Tofteland N. D., Shaver T. S., Clinical efficacy of etanercept for treatment of PAPA syndrome. Journal of Clinical Rheumatology 2010 16 5 244 245 10.1097/RHU.0b013e3181e969b9
    • (2010) Journal of Clinical Rheumatology , vol.16 , Issue.5 , pp. 244-245
    • Tofteland, N.D.1    Shaver, T.S.2
  • 152
    • 84864774809 scopus 로고    scopus 로고
    • Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab
    • article 452
    • Lee H., Park S. H., Kim S. K., Choe J. Y., Park J. S., Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab. Clinical and Experimental Rheumatology 2012 30 article 452
    • (2012) Clinical and Experimental Rheumatology , vol.30
    • Lee, H.1    Park, S.H.2    Kim, S.K.3    Choe, J.Y.4    Park, J.S.5
  • 154
    • 14944380059 scopus 로고    scopus 로고
    • Anakinra for flares of pyogenic arthritis in PAPA syndrome [5]
    • DOI 10.1093/rheumatology/keh479
    • Dierselhuis M. P., Frenkel J., Wulffraat N. M., Boelens J. J., Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology 2005 44 3 406 408 2-s2.0-14944380059 10.1093/rheumatology/keh479 (Pubitemid 40361307)
    • (2005) Rheumatology , vol.44 , Issue.3 , pp. 406-408
    • Dierselhuis, M.P.1    Frenkel, J.2    Wulffraat, N.M.3    Boelens, J.J.4
  • 155
    • 71149085612 scopus 로고    scopus 로고
    • Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
    • 2-s2.0-71149085612 10.1111/j.1365-2133.2009.09404.x
    • Brenner M., Ruzicka T., Plewig G., Thomas P., Herzer P., Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. British Journal of Dermatology 2009 161 5 1199 1201 2-s2.0-71149085612 10.1111/j.1365-2133.2009.09404.x
    • (2009) British Journal of Dermatology , vol.161 , Issue.5 , pp. 1199-1201
    • Brenner, M.1    Ruzicka, T.2    Plewig, G.3    Thomas, P.4    Herzer, P.5
  • 157
    • 84874243013 scopus 로고    scopus 로고
    • Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment
    • 10.1001/2013.jamadermatol.717
    • Geusau A., Mothes-Luksch N., Nahavandi H., Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment. JAMA Dermatology 2013 149 209 215 10.1001/2013. jamadermatol.717
    • (2013) JAMA Dermatology , vol.149 , pp. 209-215
    • Geusau, A.1    Mothes-Luksch, N.2    Nahavandi, H.3
  • 158
    • 84863521758 scopus 로고    scopus 로고
    • Deficiency of interleukin-1-receptor antagonist syndrome: A rare auto-inflammatory condition that mimics multiple classic radiographic findings
    • 2-s2.0-79960565644 10.1007/s00247-011-2208-y
    • Thacker P. G., Binkovitz L. A., Thomas K. B., Deficiency of interleukin-1-receptor antagonist syndrome: a rare auto-inflammatory condition that mimics multiple classic radiographic findings. Pediatric Radiology 2012 42 495 498 2-s2.0-79960565644 10.1007/s00247-011-2208-y
    • (2012) Pediatric Radiology , vol.42 , pp. 495-498
    • Thacker, P.G.1    Binkovitz, L.A.2    Thomas, K.B.3
  • 160
    • 84862689250 scopus 로고    scopus 로고
    • Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis
    • 10.1001/archdermatol.2011.3208
    • Minkis K., Aksentijevich I., Goldbach-Mansky R., Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis. Archives of Dermatology 2012 148 747 752 10.1001/archdermatol.2011.3208
    • (2012) Archives of Dermatology , vol.148 , pp. 747-752
    • Minkis, K.1    Aksentijevich, I.2    Goldbach-Mansky, R.3
  • 161
    • 82455210511 scopus 로고    scopus 로고
    • The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist
    • 2-s2.0-82455210511 10.1002/art.30565
    • Stenerson M., Dufendach K., Aksentijevich I., Brady J., Austin J., Reed A. M., The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Arthritis & Rheumatism 2011 63 12 4018 4022 2-s2.0-82455210511 10.1002/art.30565
    • (2011) Arthritis & Rheumatism , vol.63 , Issue.12 , pp. 4018-4022
    • Stenerson, M.1    Dufendach, K.2    Aksentijevich, I.3    Brady, J.4    Austin, J.5    Reed, A.M.6
  • 164
    • 84858741702 scopus 로고    scopus 로고
    • Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: Excellent response to anakinra
    • 2-s2.0-84858741702 10.1001/archdermatol.2011.2857
    • Brau-Javier C.N. Gonzales-Chavez J. Toro J.R. Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: Excellent response to anakinra Archives of Dermatology 2012 148 3 301-304.
    • (2012) Archives of Dermatology , vol.148 , Issue.3 , pp. 301-304
    • Brau-Javier, C.N.1    Gonzales-Chavez, J.2    Toro, J.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.